CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($) $ in Thousands	Series A Preferred Stocks [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Dec. 31, 2021	$ 0	$ 12	$ 124,225	$ (124,193)	$ 44
Beginning balance, shares at Dec. 31, 2021	14	11,944,600
Net loss				(16,281)	(16,281)
Stock based compensation		$ 1	7,705		7,706
Stock based compensation, shares		534,508
Anti-dilution provision			2,123		2,123
Anti-Dilution Provision, shares		451,957
Common stock issued for forbearance			10		10
Common stock issued for forbearance, shares		10,967
Option exercise			20		20
Option exercise, shares		42,105
Common stock issued for patents			407		407
Common stock issued for patents, shares		225,000
Common stock cancelled
Common stock cancelled, shares		(126,315)
Net proceeds from sale of common shares		$ 4	13,391		13,395
Net proceeds from sale of common shares, shares		3,614,458
Ending balance, value at Dec. 31, 2022	$ 0	$ 17	147,881	(140,474)	7,424
Ending balance, shares at Dec. 31, 2022	14	16,697,280
Net loss				(18,512)	(18,512)
Stock based compensation			3,476		3,476
Stock based compensation, shares		460,000
Option exercise			33		33
Option exercise, shares		35,528
Repricing of warrants			763	(763)
Net proceeds from sale of common shares		$ 4	8,929		8,933
Net proceeds from sale of common shares, shares		3,808,934
Issuance of shares for settlement			400		400
Stock issued for settlement, shares		250,000
Shares issued for debt extinguishment		$ 1	2,439		2,440
Shares issued for debt extinguishment, shares		1,000,000
Ending balance, value at Dec. 31, 2023	$ 0	$ 22	$ 163,921	$ (159,749)	$ 4,194
Ending balance, shares at Dec. 31, 2023	14	22,251,742